Allergan plc

Address:
Clonshaugh Business and Technology Park
Coolock, Dublin
D17 E400
Ireland

Allergan plc articles

Displaying 1 - 1 of 1

TrueTear granted marketing authorisation by the FDA

TrueTear granted marketing authorisation by the FDA
Allergan plc has announced that it has been granted marketing authorisation from the U.S. FDA for TrueTear Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients. TrueTear is a handheld stimulator with daily disposable tips that is inserted into the nasal cavity to induce the production of tears.
26th April 2017


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

SPE Offshore Europe 2017
5th September 2017
United Kingdom Aberdeen Exhibition & Conference Centre
EPE 2017 ECCE Europe
11th September 2017
Poland Warsaw
ON Semiconductor Power Seminars 2017
11th September 2017
United Kingdom
DSEI 2017
12th September 2017
United Kingdom ExCeL, London
RWM 2017
12th September 2017
United Kingdom NEC, Birmingham